About
Nitinotes Surgical is a pre-commercial medical device company based in Caesarea, Israel, founded in 2014. The company specializes in innovative, minimally invasive solutions for obesity treatment, focusing on developing endoscopic devices that enhance traditional bariatric surgery. Their flagship product, EndoZip™, is an automated endoscopic suturing system designed for endoscopic sleeve gastroplasty (ESG). This system simplifies the suturing process, allowing for consistent and safe procedures that can be performed by a single operator. The EndoZip™ system targets patients with class I and II obesity who may not be suitable candidates for traditional bariatric surgery. It offers a minimally invasive alternative that can be conducted in outpatient clinics without general anesthesia, making obesity treatment more accessible. Nitinotes is currently conducting pivotal clinical trials in the U.S. and has received FDA IDE approval, with plans for commercial launch in Europe. The company aims to broaden clinical adoption and improve patient outcomes through its innovative technology.
Technologies
Keywords
Company Information
-
Employees 31
-
Founded 2014
-
Annual Revenue $2800000
Location
5 HaEshel Street, Caesarea, Haifa District, Israel